| | Clinical Trials | In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM Study) This Phase 1 clinical trial, sponsored by UCSF and the California Institute for Regenerative Medicine, seeks pregnant women with fetuses from 18 weeks and 0/7 days to 26 weeks 0/7 days gestation with a fetal diagnosis of alpha-thalassemia major by chorionic villus sampling, amniocentesis, cordocentesis, or by identification of parents as genetic carriers and identification of fetal anemia or signs of impending hydrops, for whom parents elect to pursue in utero transfusion for the remainder of gestation. The study is to be conducted at UCSF in San Francisco, CA. Understanding the Postpartum Pain Experience in Women of Minority Race/Ethnicity This observational study, sponsored by Northwestern University and the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), seeks pregnant and postpartum women age 16 years or older who either receive publicly funded prenatal care or are uninsured. The study is to be conducted at the Northwestern Memorial Hospital in Chicago, IL. |
No comments:
Post a Comment